Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN Charles Armbruster
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
Alum Mike Deniszczuk fostering new generation of entrepreneurs through support of UMSL’s Entrepreneurship and Innovation Center
Deniszczuk received his BSBA from UMSL’s College of Business Administration in 1977 and went on to a nearly 40-year career at PricewaterhouseCoopers.
MORE IN Charles Armbruster
LATEST NEWS
- Alum Mike Deniszczuk fostering new generation of entrepreneurs through support of UMSL’s Entrepreneurship and Innovation Center
- Assistant Professor Dan Grossman earns high marks for innovative, engaging online classes
- With 8 new Fellows on board, the Coro Fellows Program in St. Louis celebrates 50 years of developing emerging leaders
- Eye on UMSL: ‘Turn Upon Them: Reveal to Heal’
- Blanche M. Touhill Performing Arts Center catering to guests with an array of interests from across the St. Louis region
- Biology PhD alum Eliot Miller taps into new data sources to study bird populations and advocate for habitat preservation
- UMSL Tritons weekly rewind
- Mother-daughter bond inspires Makeba and Tanys Giles to tackle school together
- Eye on UMSL: Stomp the Yard
- Fall Involvement Jamboree offers opportunities for students to get involved on campus
